MENU
Advertisement
Show Filters
Refine by Content Type
Refine by Year
Sort By:
Choose Sites to Search:
Sponsored by Abbott
Navitor With NaviSeal™ Cuff
With Serge Rousselle, DVM, ACVP; Keith High; Michael J. Reardon, MD; Xi Wang, MD; Lars Sondergaard, MD, DMSc; Rutger-Jan Nuis, MD, PhD; and Nicolas Van Mieghem, MD, PhD
Lotus Valve
A look at the future of percutaneous valve replacement.
By Ian T. Meredith, MBBS, PhD; Kristin L. Hood, PhD; Dominic J. Allocco, MD; and Keith D. Dawkins, MD
Supira’s SUPPORT II Pivotal Trial of pVAD System Approved by FDA
April 9, 2026—Supira Medical, Inc. announced FDA approval to initiate the SUPPORT II pivotal trial of the Supira percutaneous ventricular assist device (pVAD) system.
Biosensors' LEADERS FREE II BioFreedom Pivotal Study Begins Enrollment
February 15, 2017—Biosensors International Group, Ltd. announced that it has started enrollment in the new BioFreedom pivotal study, called LEADERS FREE II.
InnovHeart Raises Financing to Develop Saturn Transseptal TMVR System
January 27, 2022—InnovHeart s.r.l., a developer of transcatheter mitral valve replacement (TMVR) systems for the treatment of mitral valve disease, announced the closing of its Series C financing with the granting of an exclusive licensing agreement to Grand Pharmaceutical Group Limited (Grand Pharma) for InnovHeart’s Saturn device in Greater China.
In Memoriam: Medtech Pioneer Dr. Thomas J. Fogarty, 1934-2025
January 14, 2026—Family, friends, and colleagues are remembering Thomas J. Fogarty, MD, who died at age 91 on December 28, 2025.
